Kalaris Therapeutics Inc
NASDAQ:KLRSBiotechnology
Healthcare
$2.30 +3.52%
+$0.16 today
- Market cap
- $54.75M
- Beta
- 0.14
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$1.86
52W Low $2.14High $11.88
Volume 0.07M
Average 0.08M
Price history
Kalaris Therapeutics Inc SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-66.67%
Period high
$10.98
Period low
$2.30
Latest
$2.30
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Oct 26, 2026 | Oct 26, 2026 |
Competitors
Who does Kalaris Therapeutics Inc compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about KLRS's filings, answered from its disclosures.
What is the latest KLRS filing?
The latest filing shown is SC 13G dated Oct 26, 2026.
How many recent filings does KLRS have?
Intrinsic Alpha currently shows 1 recent filings for KLRS.
Continue the stock analysis
Jump to another research area for this company.